Guillain-Barré syndrome epidemiology and demographics: Difference between revisions
(Created page with " {{Guillain-Barré syndrome}} {{CMG}}; '''Associate Editors-In-Chief:''' Priyamvada Singh, MBBS [mailto:psingh@perfuse.org] ==Overview== '''Guillain-Ba...") |
No edit summary |
||
| Line 6: | Line 6: | ||
==Overview== | ==Overview== | ||
'''Guillain-Barré syndrome''' ('''GBS''') is an acute, autoimmune, [[neuropathy|polyradiculoneuropathy]] affecting the [[peripheral nervous system]], usually triggered by an acute infectious process. It is included in the wider group of [[peripheral neuropathy|peripheral neuropathies]]. There are several types of GBS, but unless otherwise stated, GBS refers to the most common form, acute inflammatory demyelinating polyneuropathy (AIDP). It is frequently severe and usually exhibits as an ascending paralysis noted by weakness in the legs that spreads to the upper limbs and the face along with complete loss of deep tendon reflexes. With prompt treatment of [[plasmapheresis]] followed by [[immunoglobulins]] and supportive care, the majority of patients will regain full functional capacity. However, death may occur if severe pulmonary complications and [[dysautonomia]] are present.==Epidemiology and demographics== | '''Guillain-Barré syndrome''' ('''GBS''') is an acute, autoimmune, [[neuropathy|polyradiculoneuropathy]] affecting the [[peripheral nervous system]], usually triggered by an acute infectious process. It is included in the wider group of [[peripheral neuropathy|peripheral neuropathies]]. There are several types of GBS, but unless otherwise stated, GBS refers to the most common form, acute inflammatory demyelinating polyneuropathy (AIDP). It is frequently severe and usually exhibits as an ascending paralysis noted by weakness in the legs that spreads to the upper limbs and the face along with complete loss of deep tendon reflexes. With prompt treatment of [[plasmapheresis]] followed by [[immunoglobulins]] and supportive care, the majority of patients will regain full functional capacity. However, death may occur if severe pulmonary complications and [[dysautonomia]] are present. | ||
==Epidemiology and demographics== | |||
===USA=== | ===USA=== | ||
* It is the commonest cause of '''acute, flaccid''' paralysis in USA. | * It is the commonest cause of '''acute, flaccid''' paralysis in USA. | ||
| Line 12: | Line 14: | ||
===Age=== | ===Age=== | ||
* Incidences increases with age. | * Incidences increases with age. | ||
==References== | ==References== | ||
{{reflist|2}} | {{reflist|2}} | ||
{{WH}} | {{WH}} | ||
{{WS}} | {{WS}} | ||
Revision as of 21:30, 17 February 2012
|
Guillain-Barré syndrome Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Guillain-Barré syndrome epidemiology and demographics On the Web |
|
American Roentgen Ray Society Images of Guillain-Barré syndrome epidemiology and demographics |
|
FDA on Guillain-Barré syndrome epidemiology and demographics |
|
CDC on Guillain-Barré syndrome epidemiology and demographics |
|
Guillain-Barré syndrome epidemiology and demographics in the news |
|
Blogs on Guillain-Barré syndrome epidemiology and demographics |
|
Risk calculators and risk factors for Guillain-Barré syndrome epidemiology and demographics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editors-In-Chief: Priyamvada Singh, MBBS [2]
Overview
Guillain-Barré syndrome (GBS) is an acute, autoimmune, polyradiculoneuropathy affecting the peripheral nervous system, usually triggered by an acute infectious process. It is included in the wider group of peripheral neuropathies. There are several types of GBS, but unless otherwise stated, GBS refers to the most common form, acute inflammatory demyelinating polyneuropathy (AIDP). It is frequently severe and usually exhibits as an ascending paralysis noted by weakness in the legs that spreads to the upper limbs and the face along with complete loss of deep tendon reflexes. With prompt treatment of plasmapheresis followed by immunoglobulins and supportive care, the majority of patients will regain full functional capacity. However, death may occur if severe pulmonary complications and dysautonomia are present.
Epidemiology and demographics
USA
- It is the commonest cause of acute, flaccid paralysis in USA.
- Incidence- 1.2 - 3 /100,000 persons
Age
- Incidences increases with age.